Pharmacological reactivation of inactive genes: The fragile X experience

Brain Research Bulletin

Volumn 56, Issue 3-4, 2001, Pages 383-387

  Chiurazzi, Pietro ^a   Neri, Giovanni ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

4 Phenylbutyrate; 5 Azadeoxycytidine; DNA demethylation; Fragile X; Histone hyperacetylation

Indexed keywords

4 PHENYLBUTYRIC ACID; AZACITIDINE; BUTYRIC ACID; HISTONE; HISTONE DEACETYLASE; POLYGLUTAMINE; RNA BINDING PROTEIN; TRICHOSTATIN A;

CONFERENCE PAPER; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; FRAGILE X SYNDROME; GENE INACTIVATION; GENETIC TRANSCRIPTION; HUMAN; MENTAL DEFICIENCY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRINUCLEOTIDE REPEAT;

ANTINEOPLASTIC AGENTS; AZACITIDINE; ENZYME INHIBITORS; FRAGILE X SYNDROME; GENE SILENCING; HUMANS; PHENYLBUTYRATES; TRINUCLEOTIDE REPEATS;

EID: 0035503145     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00571-8     Document Type: Conference Paper

References (62)

1. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR1 expression in the human fetal brain
2. Human and murine FMR1; Alternative splicing and translational initiation downstream of the CGG repeat
3. FMR1 protein; Conserved RNP family domains and selective RNA binding
4. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease
5. Transgenic mouse models of neurodegenerative disease caused by CAG/polyglutamine expansions
6. Creation of genomic methylation patterns
7. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
8. In vitro reactivation of the FMR1 gene involved in fragile X syndrome
9. Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene
10. Acetylated histones are associated with FMR1 in normal but not fragile X syndrome cells
11. Abnormal dendritic spines in fragile X knockout mice; Maturation and pruning deficits
12. The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes
13. Secondary structures in d(CGG) and d(CCG) repeat tracts
14. A point mutation in the FMR1 gene associated with fragile X mental retardation
15. Variable FMR1 gene methylation leads to variable phenotype in 3 males from one fragile X family
16. The FMR1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation
17. Evolution of simple repeats in DNA and their relation to human disease
18. DNA methylation models histone acetylation
19. Cell death in polyglutamine diseases
20. Translational suppression by trinucleotide repeat expansion at FMR1
21. FMRP associates with polyribosomes as an mRNP and the I304N mutation of severe fragile X syndrome abolishes this association
22. Fragile X syndrome and deletions in FMR1; New case and review of the literature
23. Identification and characterization of a family of mammalian methyl-CpG binding proteins
24. Tissue specific expression of FMR1 provides evidence for a functional role in fragile X syndrome
25. Analysis of neocortex in three males with the fragile X syndrome
26. Evidence for altered fragile-X mental retardation protein expression in response to behavioral stimulation
27. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
28. The fragile X mental retardation protein is associated with ribosomes
29. Stalling of human DNA (cytosine-5) methyltransferase at single-strand conformers from a site of dynamic mutation
30. The CAG/polyglutamine tract diseases; Gene products and molecular pathogenesis
31. Interaction of the transcription factors USF1, USF2, and α-Pal/Nrf-1 with the FMR1 promoter
32. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA
33. Triplet repeat expansion in neuromuscular disease
34. Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome
35. Evidence that methylation of the FMR1 locus is responsible for variant phenotypic expression of the fragile X syndrome
36. A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome
37. Trinucleotide repeats associated with human disease
38. Epilepsy and fragile X syndrome; A follow-up study
39. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
40. X-linked mental retardation
41. (Over)correction of FMR1 deficiency with YAC transgenics; Behavioral and physical features
42. Absence of expression of the FMR-1 gene in fragile X syndrome
43. Neuroanatomy of fragile X syndrome; The posterior fossa
44. Neuroanatomy in fragile X females; The posterior fossa
45. Neuroanatomy of fragile X syndrome; The temporal lobe
46. Neurodevelopmental effects of the FMR1 full mutation in humans
47. Intracellular inclusions, pathological markers in diseases caused by expanded polyglutamine tracts?
48. Fragile X mental retardation; Prevalence in a group of institutionalized patients in Italy and description of a novel EEG pattern
49. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein
50. Alternative splicing of exon 14 determines nuclear or cytoplasmic localisation of FMR1 protein isoforms
51. Normal phenotype in two brothers with a full FMR1 mutation
52. Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1
53. FMRP is associated to the ribosomes via RNA
54. An extensive de novo deletion removing FMR1 in a patient with mental retardation and the fragile X phenotype
55. Prevalence of fragile X syndrome
56. Characterization and localization of the FMR1 gene product associated with fragile X syndrome
57. Characterization of FMR1 proteins isolated from different tissues
58. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome
59. Alternative splicing in the fragile X gene FMR1
60. FMR1 fully expanded mutation with minimal methylation in a high functioning fragile X male
61. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation
62. Synaptic synthesis of the Fragile X protein; Possible involvement in synapse maturation and elimination